CVS Bay Area Inc.
Fiscal Year Ending February 2027 Q2 (Interim) Financial Summary
For the interim period of the fiscal year ending February 2027, consolidated results were: net sales 4,024 million yen, operating income 77 million yen, ordinary income 81 million yen, and interim net income attributable to owners of parent 62 million yen. Performance varied across segments such as hotels, condominium front services, and convenience stores. Full-year forecasts are unchanged. Cash and cash equivalents decreased while total assets increased. Dividends at the end of Q2 remain as planned.
Key Figures
- Net Sales: 4,024 million yen (Year-over-Year 1.2% increase)
- Operating Income: 77 million yen (Year-over-Year 241.3% increase)
- Interim Net Income Attributable to Owners of Parent: 62 million yen (previous interim was a 66 million yen interim net loss attributable to owners of parent)
AI要約
Overview of Results
In this interim period, total operating revenue increased slightly to 4,024 million yen, showing growth versus the prior year. Operating income, ordinary income, and interim net income attributable to owners of parent all increased. By segment, the hotel business, condominium front services, and convenience store business contributed, but higher personnel and advertising expenses resulted in profits falling short of plan. Full-year forecasts are unchanged from the previously announced figures. The capital position showed an increase in total assets and a slight increase in net assets. Cash and cash equivalents decreased.
Segment Trends and Outlook
The hotel business exceeded prior-year sales and segment profit increased significantly. Condominium front services promoted higher-margin proposals amid fluctuating order volumes. The cleaning business and convenience store business experienced mixed results in sales and profit, with the convenience stores performing well following the introduction of a new delivery service. Other businesses saw a slight decline. Going forward, improvement in both demand-supply dynamics and cost control is expected to remain a key challenge.
CVS Bay Area Inc.
Company overview · Stock price · Financial data · All IR
